Iberdomide in Intermediate- and High-Risk Smoldering Myeloma (SMM) Patients: a Phase 2 Study with a Safety Run-in
Latest Information Update: 11 Feb 2025
At a glance
- Drugs Dexamethasone (Primary) ; Iberdomide (Primary)
- Indications Smoldering multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 11 Feb 2025 New trial record